Stay updated on ESCAPE-NEXT: Nerinetide Efficacy in Stroke Clinical Trial
Sign up to get notified when there's something new on the ESCAPE-NEXT: Nerinetide Efficacy in Stroke Clinical Trial page.

Latest updates to the ESCAPE-NEXT: Nerinetide Efficacy in Stroke Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNaples, Italy is listed as a study location, replacing Napoli, Italy, and the page revision is updated to v3.5.0.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page revision tag was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.4.1 is now displayed, replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page's revision entry was updated from Revision: v3.3.3 to Revision: v3.3.4, replacing the previous revision label.SummaryDifference0.0%

- Check103 days agoChange DetectedThe page now consolidates all trial sites under a single Locations section, listing participating sites across the United States and Canada (Arizona, California, Colorado, Florida, Georgia, Maryland, Massachusetts, New York, Ohio, Oregon, Pennsylvania, Rhode Island, Texas, Washington, Alberta, British Columbia, Manitoba, Nova Scotia, Ontario, Quebec, Saskatchewan) and replaces the previous state- or province-specific subsections.SummaryDifference1%

Stay in the know with updates to ESCAPE-NEXT: Nerinetide Efficacy in Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ESCAPE-NEXT: Nerinetide Efficacy in Stroke Clinical Trial page.